Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esperanza Such

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|March 27, 2025
Exploring the Potential of Optical Genome Mapping in the Diagnosis and Prognosis of Soft Tissue and Bone TumorsAlejandro Berenguer-Rubio, Esperanza Such, Neus Torres Hernández, et al.
Cancers|June 10, 2023
Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome MappingÁlvaro Díaz-González, Elvira Mora, Gayane Avetisyan, et al.
Haematologica|November 27, 2010
Cytogenetic risk stratification in chronic myelomonocytic leukemiaEsperanza Such, José Cervera, Dolors Costa, et al.
Blood Advances|October 28, 2025
OPTICAL GENOME MAPPING IN MYELOFIBROSIS: ENHANCING PROGNOSTIC ACCURACY THROUGH HIGH-RESOLUTION GENOMIC PROFILINGÁlvaro Díaz González, Elvira Mora, Marta Garrote, et al.
Genes, Chromosomes & Cancer|May 21, 2013
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotypeDolors Costa, Concha Muñoz, Ana Carrió, et al.
Genes, Chromosomes & Cancer|December 23, 2015
Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromesMeritxell Nomdedeu, Xavier Calvo, Arturo Pereira, et al.
British Journal of Haematology|April 4, 2018
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registriesMaría Díez-Campelo, Jose I Lorenzo, Raphael Itzykson, et al.
Cell Reports. Medicine|December 20, 2023
NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapyLaura Hurtado-Navarro, Ernesto José Cuenca-Zamora, Lurdes Zamora, et al.
Leukemia Research|January 23, 2013
Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?Vera Ademà, Jesús María Hernández, María Abáigar, et al.
Haematologica|July 2, 2008
Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-Mar Mallo, Leonor Arenillas, Blanca Espinet, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|March 27, 2025
Exploring the Potential of Optical Genome Mapping in the Diagnosis and Prognosis of Soft Tissue and Bone TumorsAlejandro Berenguer-Rubio, Esperanza Such, Neus Torres Hernández, et al.
Cancers|June 10, 2023
Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome MappingÁlvaro Díaz-González, Elvira Mora, Gayane Avetisyan, et al.
Haematologica|November 27, 2010
Cytogenetic risk stratification in chronic myelomonocytic leukemiaEsperanza Such, José Cervera, Dolors Costa, et al.
Blood Advances|October 28, 2025
OPTICAL GENOME MAPPING IN MYELOFIBROSIS: ENHANCING PROGNOSTIC ACCURACY THROUGH HIGH-RESOLUTION GENOMIC PROFILINGÁlvaro Díaz González, Elvira Mora, Marta Garrote, et al.
Genes, Chromosomes & Cancer|May 21, 2013
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotypeDolors Costa, Concha Muñoz, Ana Carrió, et al.
Genes, Chromosomes & Cancer|December 23, 2015
Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromesMeritxell Nomdedeu, Xavier Calvo, Arturo Pereira, et al.
British Journal of Haematology|April 4, 2018
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registriesMaría Díez-Campelo, Jose I Lorenzo, Raphael Itzykson, et al.
Cell Reports. Medicine|December 20, 2023
NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapyLaura Hurtado-Navarro, Ernesto José Cuenca-Zamora, Lurdes Zamora, et al.
Leukemia Research|January 23, 2013
Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?Vera Ademà, Jesús María Hernández, María Abáigar, et al.
Haematologica|July 2, 2008
Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-Mar Mallo, Leonor Arenillas, Blanca Espinet, et al.
Pageof 9